Monod Bio Licenses Protein Technologies to SignalChem Biotech

August 26, 2026
Monod Bio and SignalChem Biotech signed a nonexclusive license for LuxSit luciferase technology and NovoBodies for custom luminescent assays and protein fusion services.

Monod Bio and SignalChem Biotech announced in a press release a licensing agreement for Monod Bio's LuxSit luciferase technology and NovoBodies.

The agreement is not exclusive. SignalChem Biotech may use the technologies in custom luminescent assays and protein fusion services for research customers.

LuxSit is a luciferase designed with AI for use in luminescent biosensors. NovoBodies are compact binding proteins designed for target recognition.

SignalChem Biotech is a wholly owned subsidiary of Sino Biological. The companies did not disclose financial terms.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

09/05
ASUS Expands AI Infrastructure From Cloud to Edge
09/05
Haier Shows AI Smart Home Ecosystem at IFA 2026
09/05
Harvey and Everlaw Connect Legal AI With Discovery Evidence
09/04
Ramp Adds Finance Platform to AWS Marketplace
09/04
LiveU Joins IBC Project to Develop Newsroom Context Standard

More from: Life Sciences

09/05
HoneyNaps Develops Wireless Sleep Monitoring System With Four Skin Patches
09/05
Carestream Updates DRX LC Detector With AI Noise Reduction
09/05
EClinCloud AI Platform Supports More Than 1,100 Clinical Trials
09/05
Tuya Smart Unveils Doova Home Robot for Seniors at IFA 2026
09/04
ODYSS Unveils N1 AI Necklace for Food Logging

Subscribe to Enterprise AI Brief

Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You May Also Like